Venus Remedies introduces a new arthritis drug
The pharma company launches a new drug named Trois for the treatment of Arthritis.
Chandigarh, August 22, 2012: With an aim to provide relief from all sorts of arthritic pains, Venus Remedies has launched a new arthritis drug named Trois for the treatment of arthritis in the country.
“We felt the pressing need to develop an alternative solution for rheumatic disorders and related infections, thus have come up for the first time with a topical nano emulsion ‘Trois’ to relieve arthritic pain,” said Manu Chaudhary, Joint Managing Director and Director - Research, Venus Remedies.
Reports suggest that close to 15 per cent of the Indian population is suffering from this disease.
“With the kind of response we are getting for this revolutionary nano tech emulsion in pain management as topical pain killer in arthritis, we are hopeful of capturing a significant share of the rheumatoid arthritis drug market in India, which is estimated to grow up to US$ 672 million in 2013,” said Dheeraj Aggarwal, CFO, Venus Remedies.
It may be noted here that the Panchkula-based company has already filed patents for Trois in all major markets across the globe and following the approvals, the company is planning to launch this product in the international market as well.